KIT and cardiomyopathy: The CONCERT-HF trial is recruiting patients to investigate the safety and efficacy of autologous bone marrow-derived MSCs and c-kit+ CSCs both alone and in combination for the treatment of ischaemic cardiomyopathy [115].